Kaya Holdings (KAYS) FCF Margin Growth (1y) (2015 - 2025)

Kaya Holdings (KAYS) FCF Margin Growth (1y) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 74.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -1,043.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -573.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 734.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 301.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -45,890.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 407.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 610.00
10 Kaya Holdings - - 5,370.00 -7,777.00

Historic Data

Download Data
DateValue
Sep 30, 2025 -7,777.00
Mar 31, 2025 -218,023.00
Dec 31, 2024 236,553.00
Sep 30, 2024 -88,630.00
Mar 31, 2024 22,268.00
Dec 31, 2023 -77,951.00
Sep 30, 2023 -18,773.00
Jun 30, 2023 -41,806.00
Mar 31, 2023 -45,392.00
Dec 31, 2022 7,536.00
Sep 30, 2022 -1,796.00
Jun 30, 2022 -11,447.00
Mar 31, 2022 -10,256.00
Dec 31, 2021 -26,465.00
Sep 30, 2021 -4,941.00
Jun 30, 2021 -11,117.00
Mar 31, 2021 -3,787.00
Dec 31, 2020 4,990.00
Sep 30, 2020 7,918.00
Jun 30, 2020 4,440.00